483
Chamindra LavertyFDA 483 - Chamindra Laverty - January 14, 2026
Record Details
The FDA inspected UCSD Altman Clinical And Translational Research Institute in La Jolla, CA, and issued a Form 483. The inspection revealed that the firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, there were significant delays in the timely review of both laboratory results and (b)(4) results for an enrolled subject, indicating a serious deviation from protocol requirements.
- Person
View Company Profile
ID · 58b3762b-de91-4daa-995e-e0f8f0c9b147
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.